Mission
& Vision

Revolutionizing
Cell & Gene Therapy
Through Innovation

Contact Us

Mission
& Vision

As one of the most preeminent and complex blood centers in the world, NYBCe operates under a four (4) part mission:​ 

  • To provide the highest quality blood and stem cell products and related medical and consultative services to hospitals and patients;​ 
  • To conduct the highest quality, novel and innovative research in the fields of hematology, blood banking, transfusion medicine, and cellular therapies, thus advancing these fields and positively impacting the public health;​ 
  • To develop products, technologies, and services in the fields of hematology, blood banking, transfusion medicine, and cellular therapies with the potential for worldwide humanitarian impact;​ 
  • To train the next generation of leaders in each of these fields.​ 

With an unwavering commitment to excellence, quality, service, innovation and leadership in every area, NYBCe embraces and values the highest ethical, humanitarian, medical and scientific standards, including compassion, respect, integrity, and caring for all people, including the donor and patient, and the acquisition, sharing and application of knowledge, thus fostering a corporate and civic culture continually to earn and maintain the public trust. 

Across our organization, we are committed
to living our Enterprise Core Values T

Integrity

Demonstrating honesty and transparency in all actions and decisions.

Innovation

Encouraging new possibilities, opportunities, capabilities, and discoveries.

Quality

Achieving optimal results and going above and beyond expectations.

Excellence

Prioritizing the highest possible standards of performance in all we do.

Exemplary Service

Delivering the highest levels of expertise, responsiveness, and dependability.

Respect

Treating others with the utmost consideration, kindness, and dignity at all times.

Testimonials

Dendreon and CCS have collaborated for over a decade, with NYBC serving as a trusted apheresis partner. They provide comprehensive vein assessment services, which are a key component of the Provenge® treatment process.​ These services not only help familiarize patients with the staff and the collection center but also offer them an opportunity to ask questions and learn more about the apheresis procedure.​

Additionally, Dendreon and CCS have continued to partner in setting up apheresis collection centers to further support the Provenge® treatment process.​ Having worked closely with the CCS team on a variety of initiatives, I can confidently say that they are dedicated, patient-focused, and committed to excellence.

Wilbeth Flojo
Apheresis Account Manager, Dendreon